The talk around motherhood is changing in ways that, not long ago, did not seem possible. Not just regarding how mothers are coping but in what they're willing to say out loud about it.

For years, the cannabis-and-motherhood conversation happened in whispers: in group chats, in anonymous forums, in the parking lot after school pickup. The stigma was too thick, the legal risk too real, the cultural image of the "bad mom" too close. Mothers using cannabis to manage anxiety, endometriosis, and chronic pain told researchers last year they felt like more present, more effective parents — and lived in daily fear of being labeled otherwise. The study, published in Drug and Alcohol Review, captured the calculation plainly: "They might take my baby away."

But in 2026, the ground has shifted enough to have a different conversation — one that is more honest, science-grounded, and urgent than the one we've been having. Twenty-four states plus Washington D.C. have legalized adult-use cannabis. Eighty-seven percent of Americans now support some form of legalization. The Surgeon General has issued a formal cancer advisory about alcohol. Daily cannabis users in the U.S. now outnumber daily drinkers for the first time in recorded history. And a generation of millennial mothers — many of them newly diagnosed with ADHD or autism, facing perimenopause, and many of them burning out quietly behind a facade of competence — is asking, with increasing directness: why is the thing that actually helps me the one we're not allowed to talk about?

What Motherhood Actually Looks Like Right Now

The numbers on modern motherhood are not subtle. Between 2016 and 2023, the share of U.S. mothers reporting excellent mental health dropped from 38% to 26% — a collapse that began, notably, before the pandemic. Published last spring in JAMA Internal Medicine, the study drew on data from nearly 200,000 U.S. mothers and found the share reporting fair or poor mental health rose 64% over that same period. "These declines originated before the pandemic," said lead researcher Jamie Daw of Columbia University's Mailman School of Public Health, "suggesting this is due to broader societal and population-level pressures."

The Surgeon General's 2024 advisory, "Parents Under Pressure," added its own stark figures: 41% of parents say they are so stressed they cannot function on most days. Nearly half feel completely overwhelmed. One in five U.S. mothers will experience a maternal mental health condition this year, and 75% of them will never receive treatment. Meanwhile, mothers perform 73% of all cognitive household labor — the invisible, unceasing work of tracking, planning, anticipating, managing — according to a 2024 University of Southern California analysis.

And yet the cultural script hasn't changed. Good moms handle it. Good moms show up. Good moms, if they need to take the edge off, pour a glass of wine — because that's what the memes say, what the merchandise says, what decades of "mommy juice" culture has quietly codified as the socially acceptable way for mothers to cope.

What the merchandise doesn't mention is that the Surgeon General formally classified alcohol as the third leading preventable cause of cancer in America earlier this year, linked to seven cancer types and approximately 20,000 U.S. cancer deaths annually. Breast cancer risk increases with as little as one drink per day. Heavy drinking days among women rose 41% during the pandemic, per JAMA Health Forum. Less than half of Americans know any of this — which means the coping tool we've handed mothers, gift-wrapped in a "Rosé All Day" tote bag, is the one the science is most worried about.

Meanwhile, cannabis — still stigmatized, still federally Schedule I, still capable of triggering a CPS investigation in states where it has been legal for years — is quietly becoming the tool a growing number of mothers are actually reaching for. The numbers, pulled from a decade of federal drug use surveys and published this year in Drug and Alcohol Dependence, show roughly one in 19 U.S. parents now uses cannabis daily or near-daily, up from one in 80 in 2012. Daily parental cannabis use now exceeds daily parental alcohol use by a factor of four. Fifty-seven percent of cannabis-using parents, per a Harris Poll, say their use has replaced or reduced how much they drink. The cultural double standard here is not subtle either.

Your Body Already Knows About Cannabis

Here's something that gets left out of most conversations about mothers and cannabis: you were born with a system designed to work with it.

The endocannabinoid system — discovered in 1988 and still underrepresented in mainstream health education — is one of the most widely distributed regulatory networks in the human body. It's built from two types of receptors (CB1, concentrated in the brain regions governing fear, memory, and emotional regulation; CB2, found in immune tissue), naturally occurring compounds the body produces called endocannabinoids, and the enzymes that make and break them down.

Its job is to help your body return to baseline after stress. Think of it as a thermostat. When something activates your stress response, the ECS releases compounds that tap the brakes — dampening alarm signals in the amygdala, helping the prefrontal cortex come back online, allowing recovery rather than a system stuck in threat mode. A comprehensive 2020 review in Dialogues in Clinical Neuroscience described it as a primary modulator of fear, anxiety, and stress response.

The catch: chronic stress depletes the system. Under sustained pressure, natural endocannabinoid levels drop, receptors desensitize, and the thermostat starts to fail. Neurologically speaking, that is what burnout looks like.

THC mimics the body's own endocannabinoids and binds directly to CB1 receptors. CBD raises those levels more indirectly, by blocking the enzyme that breaks them down. Both can produce calming effects, but not without nuance. In a landmark 2017 study out of the University of Illinois at Chicago, researcher Emma Childs gave oral THC to healthy adults before a stress task. At 7.5 mg, it reduced subjective stress. At 12.5 mg, anxiety and negative mood increased. A 2023 review in Current Addiction Reports confirmed that pattern across multiple studies and added something critical for this audience: women experience significantly greater anxiety responses to higher doses of THC than men do, even at equivalent body weight and blood levels.

Overall, the science supports intentional, low-dose use – not treating a one-hitter like a bottle of Merlot, if we’re being honest. But studies are starting to look into habitual use, too.

The Mother Who Doesn't Have a Diagnosis Yet

Something else is happening beneath the burnout data that doesn't get enough attention: a quiet epidemic of late-diagnosed neurodivergence among women.

Adult ADHD diagnoses in women have surged since the pandemic — in part because the loss of external structure made previously managed symptoms impossible to ignore, and in part because recognition has simply improved. Women wait an average of four years longer than men for an ADHD diagnosis, according to a 2024 review in Frontiers in Psychiatry. Many are diagnosed in their 30s and 40s, often only after a child is diagnosed first. Autistic women follow a similar pattern — masked for decades by the effort of appearing neurotypical, burning out in ways that look, from the outside, like depression or anxiety or just not coping well enough.

For these mothers, the sensory demands of parenting are acute. A toddler's pitch. The weight of a clinging body. The cognitive load of managing a household while managing a brain that was never built for this kind of relentless, unstructured, emotionally saturated work. Research published in PMC in 2023 found that heightened sensory perception — tactile, auditory, visual — was the dominant stressor reported by autistic mothers. Last year, the AASPIRE research collaborative published a validated burnout measure distinguishing autistic burnout from clinical depression — which matters because many mothers currently treated for postpartum depression may actually be in autistic burnout, a meaningfully different condition.

The endocannabinoid system sits at the center of this picture. A 2025 scoping review in Developmental Psychobiology identified the ECS as a candidate therapeutic target in ADHD. Research published in the Journal of Attention Disorders in 2022 found adults with ADHD reported cannabis acutely improved hyperactivity, impulsivity, and the anxiety side effects of ADHD medication. A 2023 systematic review in PubMed identified the self-medication hypothesis as the leading explanatory model for why ADHD and cannabis use so often co-occur.

This is a good example of a community operating based off of lived experience and anecdotal research; running ahead of the research, as marginalized communities often do. No large studies yet specifically quantify cannabis use among neurodivergent mothers and that gap is itself worth naming. The mothers most likely to be using cannabis for nervous system support are the ones science has historically studied least.

High-Functioning Is a Lie We Tell Ourselves

There's a phrase that appears in two very different clinical contexts, and its double appearance is not a coincidence.

In neurodivergent communities, "high-functioning" describes people who can mask their symptoms well enough to pass — to hold jobs, raise children, maintain relationships, perform competence — while living privately in chronic overwhelm. The neurodiversity community has largely rejected the term, because it measures proximity to neurotypical performance rather than actual internal experience. It says: you seem fine, therefore you are fine.

In addiction medicine, "high-functioning" describes people with substance use disorders who maintain careers and family roles despite their use. Writing in Psychiatric Times last year, clinician Juana Rohaidy noted these patients are the hardest to identify and treat — they show "strong denial and heightened concern about stigma or career impact," and the people around them see someone who is coping.

The modern mother sits at the intersection of both. She is praised for functioning. She is expected to function. And when she reaches for something to make the functioning possible, the culture either looks away or judges her, depending entirely on what she reached for.

The culture is shifting, slowly. Gallup found drinking among adults under 35 fell from 72% at the start of the century to 62% by the early 2020s. In 2022, for the first time on record, daily cannabis users in the U.S. outnumbered daily drinkers — 17.7 million to 14.7 million, per Carnegie Mellon researcher Jonathan Caulkins, writing in Addiction. "It is striking," Caulkins wrote, "that high-frequency cannabis use is now more commonly reported than is high-frequency drinking." Sixty-nine percent of Americans aged 18 to 24 now prefer cannabis to alcohol, according to a 2024 CBS News survey.

The mothers leading this shift aren't doing it carelessly. Women cannabis users cite relaxation, sleep, anxiety relief, and substitution for prescription drugs as their top motivations, per a 2024 YouGov survey. More than half of cannabis-using parents say their use has replaced or reduced alcohol. These are not women escaping. These are women making a calculated trade — and by nearly every public health metric, it is a defensible one.

The Transition Nobody Prepares You For

There is yet another layer to this story – have you heard that motherhood is a journey?! –  that rarely gets named alongside burnout and neurodivergence, even though it affects the same demographic at the same time: perimenopause.

The average age of perimenopause onset is the mid-40s, which is squarely overlapping with peak parenting years for millennial mothers, and also the age during which millennial mothers’ parents are aging and need more care. The symptoms are not subtle: Disrupted sleep. Mood instability. Anxiety that arrives without warning. Cognitive fog thick enough that thinking, as one researcher put it, feels like wading through treacle. What is less understood is why cannabis is relevant here at a biological level.

Estrogen regulates FAAH — the enzyme that breaks down anandamide, the body's primary endocannabinoid. When estrogen drops or fluctuates, FAAH activity changes, anandamide levels shift, and the endocannabinoid system is directly destabilized. Research published in the Journal of Steroid Biochemistry and Molecular Biology confirmed that estrogen administration significantly increased both CB receptor expression and plasma anandamide levels — responses that were estrogen-receptor dependent. In plain terms: the hormonal chaos of perimenopause is also an endocannabinoid system disruption. The anxiety, the sleeplessness, the mood swings — they have a biological mechanism, and the ECS sits at the center of it.

A survey published in the journal Menopause found that perimenopausal women reported higher incidence of depression and anxiety than postmenopausal women, and were more likely to use cannabis specifically to address those mood and anxiety symptoms. A separate survey of 1,500 women found cannabis use during the menopause transition was primarily motivated by sleep, anxiety, and muscle and joint pain. As of 2025, no completed clinical trials have assessed cannabis specifically for menopausal symptoms — an observational study is currently underway in Australia — meaning once again, the women living this are running ahead of the research designed to validate their experience.

A perimenopausal mother of young children is managing hormonal dysregulation, endocannabinoid system depletion, chronic stress, cognitive load, and a culture that offers her Zoloft or a glass of wine and calls it support. The conversation about cannabis and motherhood is incomplete without her.

This Is Not Necessarily a Story About Getting High

It's worth being precise about what the science actually supports, because this piece is not an argument for overconsumption, and the research doesn't make one.

The Childs study is the canonical data point: 7.5 mg of oral THC reduced stress; 12.5 mg increased it. That biphasic curve — calming at low doses, anxiety-inducing at higher ones — holds across multiple human studies. The sex-specific finding from Current Addiction Reports makes it more urgent: women are more sensitive to THC's anxiogenic effects than men, at equivalent doses, a fact almost never communicated at the point of purchase.

What the evidence best supports is microdosing — 1 to 5 mg of THC, often paired with CBD or CBG. A wind-down ritual after the kids are asleep. A reset after an afternoon of sensory overload. A moment of creative quiet before the morning begins. Not escapism. Not numbing. Intentional nervous system support, using a compound that works with biology the body already has.

One honest caveat belongs here: a 2021 systematic review in Psychiatric Services found insufficient clinical trial evidence to formally recommend cannabis for anxiety, depression, or PTSD. User-reported benefit and randomized controlled trial evidence are not the same thing. What this piece argues is narrower — that in a documented maternal mental health crisis, with alcohol newly classified as a carcinogen, the conversation about what mothers are permitted to use deserves to be grounded in the actual science, not the cultural double standard. 

The Part We Still Don't Talk About Enough

Before closing, something needs to be said directly: the stigma around maternal cannabis use does not fall evenly.

White mothers posting #cannamom content on TikTok face social judgment. Black and Latina mothers face the police. In February 2026, The Marshall Project published the results of a yearlong investigation — in partnership with Reveal, Mother Jones, and USA Today — revealing that child welfare agencies in 21 states referred parents to law enforcement more than 70,000 times over alleged substance use during pregnancy over a six-year period. Investigators called that number a significant undercount. In Oklahoma, one in 24 births resulted in a referral to law enforcement. In 13 states, child welfare agencies have a policy of automatically notifying police of any positive drug test during pregnancy before an investigation has even been opened.

The tests themselves are often wrong. The Marshall Project's reporting found that hospitals routinely administer unreliable urine screenings to birthing patients, generating false positives triggered by medications the hospitals themselves administered during labor. One woman in South Carolina — Ayanna Harris-Rashid, who had used legal CBD gummies and a topical hemp ointment throughout her pregnancy — was charged with felony child neglect after she and her newborn tested positive. She was breastfeeding when the police called.

"This represents an incredibly regressive and counterproductive approach," said Dana Sussman, senior vice president of the legal advocacy organization Pregnancy Justice, in response to the findings.

Cannabis remains federally Schedule I. The legal risk of custody loss is real regardless of state law and it is not distributed equally. Any honest conversation about mothers and cannabis has to hold that fact at the center, not the margins.

The shift happening right now is real, the conversation is opening. But it is opening faster for some mothers than for others, and the ones for whom it remains most dangerous are often the ones who need it most.

So, we want to hear from you. If you're a mother with a story about cannabis, coping, and what intentional use actually looks like in your life, anonymous submissions are open. Your story matters, and so does the conversation we're building.

Submit your story here